Skip to main content
Advertisement

Aviata at Tallahassee: Pain Medication Failures - FL

Healthcare Facility:

The daughter of Resident #52 at Aviata at Tallahassee called inspectors on September 16 to report that her mother had not received her prescribed MS Contin 75 ER for several nights. The extended-release morphine medication is typically prescribed for chronic severe pain requiring around-the-clock treatment.

Aviata At Tallahassee facility inspection

When inspectors contacted the facility's pharmacy that same day, they discovered a troubling gap in medication management. The pharmacy confirmed they had filled two previous orders for the resident's morphine: a 25-day supply requested July 2 that ended August 6, and another 25-day supply requested August 4 that ended August 31.

Advertisement

No refill requests had been received since then.

The pharmacy records revealed the facility had gone more than two weeks without requesting a new supply of the resident's pain medication, despite the prescription running out at the end of August.

During interviews with the Director and Assistant Director of Nursing on September 16, staff attempted to explain their medication refill procedures. They demonstrated the process meant to prevent residents from missing medication days. But when inspectors showed them the Medication Administration Record, a more serious problem emerged.

The record showed staff had documented giving MS Contin to Resident #52 even though no medication refill had been received from the pharmacy. Staff claimed they had "some extra dosages on hand" to fulfill the order, but the documentation told a different story.

From September 10 through September 13, the Medication Record showed Resident #52 did not receive her MS Contin. Next to those dates, staff had written that the medication was "not available."

Four consecutive days without prescribed pain medication.

The facility's own records contradicted staff explanations about having extra doses available. If additional medication existed, inspectors wanted to know why the resident went without her prescribed pain relief for four straight days.

MS Contin is an extended-release formulation of morphine designed to provide consistent pain control over 12-hour periods. Patients prescribed this medication typically have chronic conditions requiring continuous pain management. Sudden discontinuation can cause withdrawal symptoms in addition to the return of underlying pain.

The nursing directors acknowledged their failure during the inspection interview. Staff stated that the MS Contin 75 mg "should have been reordered in a more timely manner."

But the admission came only after inspectors presented evidence of the medication gap and the family complaint. The facility had not proactively identified or addressed the problem.

Federal regulations require nursing homes to provide safe and appropriate pain management for residents who need such services. The failure to maintain adequate medication supplies and the documentation of doses that were never given violates these basic care standards.

The inspection found the facility failed both in medication management and in accurate record-keeping. Staff either documented giving medication they knew was unavailable, or failed to track their actual medication inventory properly.

For Resident #52, the result was the same: days without prescribed pain relief while her medical records showed she was receiving proper treatment.

The case raises questions about medication oversight at the facility. How many other residents might have experienced similar gaps in prescribed medications? How often do staff document administering drugs that aren't actually available?

The facility's pharmacy confirmed they respond to refill requests promptly. The breakdown occurred entirely within the nursing home's medication management system. Staff knew when prescriptions would run out. They had procedures in place to prevent medication gaps.

They simply didn't follow them.

Resident #52's daughter had to call state inspectors to resolve a problem the facility should have prevented. Her mother spent four documented days without prescribed morphine, with potentially more unreported days when staff falsely recorded giving medication they didn't have.

The nursing directors' acknowledgment that they "should have been more timely" understates the severity of leaving a resident in pain while maintaining false medical records. The inspection classified this as causing minimal harm, but for Resident #52, those September nights without pain relief were anything but minimal.

Full Inspection Report

The details above represent a summary of key findings. View the complete inspection report for Aviata At Tallahassee from 2025-09-19 including all violations, facility responses, and corrective action plans.

Additional Resources

🏥 Editorial Standards & Professional Oversight

Data Source: This report is based on official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).

Editorial Process: Content generated using AI (Claude) to synthesize complex regulatory data, then reviewed and verified for accuracy by our editorial team.

Professional Review: All content undergoes standards and compliance oversight by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal, using professional regulatory data auditing protocols.

Medical Perspective: As emergency medical professionals, we understand how nursing home violations can escalate to health emergencies requiring ambulance transport. This analysis contextualizes regulatory findings within real-world patient safety implications.

Last verified: May 8, 2026 | Learn more about our methodology

📋 Quick Answer

AVIATA AT TALLAHASSEE in TALLAHASSEE, FL was cited for violations during a health inspection on September 19, 2025.

The extended-release morphine medication is typically prescribed for chronic severe pain requiring around-the-clock treatment.

What this means: Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.

Frequently Asked Questions

What happened at AVIATA AT TALLAHASSEE?
The extended-release morphine medication is typically prescribed for chronic severe pain requiring around-the-clock treatment.
How serious are these violations?
Violation severity varies from minor documentation issues to serious safety concerns. Review the inspection report for specific deficiency codes and scope. All violations must be corrected within required timeframes and are subject to follow-up verification inspections.
What should families do?
Families should: (1) Ask facility administration about specific corrective actions taken, (2) Request to see the follow-up inspection report verifying corrections, (3) Check if this represents a pattern by reviewing prior inspection reports, (4) Compare this facility's ratings with other nursing homes in TALLAHASSEE, FL, (5) Report any new concerns directly to state authorities.
Where can I see the full inspection report?
The complete inspection report is available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request a copy directly from AVIATA AT TALLAHASSEE or from the state Department of Health. The report includes specific deficiency codes, facility responses, and correction timelines. This facility's federal provider number is 105433.
Has this facility had violations before?
To check AVIATA AT TALLAHASSEE's history, visit Medicare.gov's Care Compare and review their inspection history, quality ratings, and staffing levels. Look for patterns of repeated violations, especially in critical areas like abuse prevention, medication management, infection control, and resident safety.